Key result
Novel pharmacological treatments in transitional pain medicine aim to manage moderate to severe postsurgical pain and address care gaps like hospital readmission and persistent opioid use.
Why the study?
Do novel pharmacological treatments improve the management of moderate to severe postsurgical pain in postsurgical patients?
Population
Postsurgical patients with moderate to severe pain
Design
Review
Authors
Loading...
Novel agents may mitigate persistent opioid use after surgery; leaves open need for prospective trials to confirm benefits.
Do novel pharmacological treatments improve the management of moderate to severe postsurgical pain in postsurgical patients?
This review discusses novel pharmacological treatments for managing moderate to severe postsurgical pain to address gaps in care such as persistent opioid use.
Hance Clarke (2015) studied this question. Novel pharmacological treatments in transitional pain medicine aim to manage moderate to severe postsurgical pain and address care gaps like hospital readmission and persistent opioid use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: